In the 195th episode of Berkeley Talks, UC Berkeley professors explored the evolution of psychedelic substances and their effects on the human brain and mind. Gül Dölen, a psychology professor at UC Berkeley, highlighted the importance of understanding the state of susceptibility and vulnerability that occurs during psychedelic trips, comparing it to childhood learning experiences. She emphasized the need to focus on integrating the insights gained into long-term memory networks that support learned behaviors in the weeks following a trip. Dölen also stressed the importance of providing a safe and supportive environment for individuals during this critical period.
On March 27, 2024, Gül Dölen was among several panelists who participated in an event moderated by Imran Khan, executive director of the Berkeley Center for the Science of Psychedelics (BCSP). The other panelists included Daniela Kaufer, Noah Whiteman, and Michael Silver. Kaufer is a professor in Integrative Biology and Helen Wills Neuroscience Institute as well as an associate dean of biological sciences. Whiteman is a professor of Integrative Biology and Molecular Cell Biology who serves as faculty director at Essig Museum of Entomology. Silver is a professor in Herbert Wertheim School Optometry Vision Science and Helen Wills Neuroscience Institute who is also faculty director at BCSP.
The panel discussed various aspects related to psychedelics such as its history, current research findings, potential therapeutic role, safety concerns etc. They also touched upon how these substances can help individuals cope with mental health issues like depression and anxiety.
Overall, it was an enlightening discussion that sheds light on different perspectives regarding psychedelic substances from various fields such as psychology, biology, optometry and neuroscience.